13: Skin
Approved: 1 Aug 2012. Last amended: 1 Oct 2024.
On this page
-
Management of skin conditions
-
Emollient and barrier preparations
-
Antipruritics
-
Topical corticosteroids
-
Preparations for Eczema and Psoriasis
-
Acne and rosacea
-
Preparations for warts and calluses
-
Sunscreens and camouflagers
-
Shampoos and other preparations for scalp and hair conditions
-
Anti-infective skin preparations
-
Skin cleansers and antiseptics
-
Antiperspirants
-
Wound management products and elastic hosiery
-
Miscellaneous
13.1 Management of skin conditions
13.2 Emollient and barrier preparations
13.2.1 Emollients
For Emollients, please see the Gloucestershire Emollient Formulary
13.2.2 Barrier Preparations
For recommended barrier preparations, please see the Gloucestershire Woundcare Formulary
Specific Indication
Zinc and castor oil ointment
Zinc preparations are restricted to use by the dermatologists
13.3 Antipruritics
For recommended topical antipruritics, please see the Gloucestershire Emollient Formulary
Doxepin Hydrochloride 5%
Cream (Xepin®) – for small areas only. Restricted to dermatology. Doxepin cream can cause drowsiness that may affect skilled tasks and there may be a risk of sensitisation.
13.4 Topical corticosteroids
Frequency of application of topical corticosteroids for atopic eczema: NICE TA81
Head and neck
2.5 FTU/application, Approx 10g per week
Each arm
4 FTU/application, Approx 15g per week
Trunk
14 FTU/application, (7 FTU to front and 7 FTU to back), Approx 50g per week
Each leg
Each leg: 8 FTU/application, Approx 30g per week
13.4.1 Topical Steroids
13.4.1.1 Mild
Hydrocortisone 0.1, 0.5, 1.0 and 2.5%
Cream/ointment
Synalar 1 in 10 Dilution®
Cream (fluocinolone 0.0025%)
13.4.1.2 Moderate
Eumovate®
Cream/ointment (clobetasone butyrate 0.05%)
Betnovate RD®
Cream/ointment (betamethasone valerate 0.025%)
Haelan®
- Tape (fludroxycortide 4 micrograms/cm2)
- Information leaflet
Synalar 1 in 4 Dilution®
Cream/ointment (fluocinolone 0.00625%)
13.4.1.3 Potent
Betamethasone valerate 0.1%
Cream / Ointment / Lotion
Diprosalic®
Ointment (betamethasone dipropionate 0.05% with salicylic acid 3%)
Elocon®
Cream/ointment (mometasone furoate 0.1%)
13.4.1.4 Very Potent
Dermovate®
Cream/ointment (clobetasol propionate 0.05%)
Nerisone Forte®
Oily cream (diflucortolone 0.3%)
13.4.2 Topical Steroids with antimicrobials
13.4.2.1 Mild
Canesten HC®
Cream (hydrocortisone 1% and clotrimazole 1%)
Fucidin H®
Cream/ointment (hydrocortisone 1% and fusidic acid 2%)
Daktacort®
Cream/ointment (hydrocortisone 1% and miconazole 2%)
Timodine®
Cream (hydrocortisone 0.5%, nystatin 100,000 units/g, benzalkonium chloride solution 0.2% and dimeticone ‘350’ 10%)
13.4.2.2 Moderate
Trimovate®
Cream (clobetasone butyrate 0.05%,oxytetracycline 3% & nystatin 100,000 units/g)
13.4.2.3 Potent
Betnovate-C®
Cream/ointment (betamethasone 0.1% and clioquinol 3%)
Lotriderm®
Cream (betamethasone dipropionate 0.064% and clotrimazole 1%)
FuciBET®
Cream (betamethasone 0.1% and fusidic acid 2%)
Betnovate N®
Cream /ointment (betamethasone 0.1% and neomycin 0.5%)
Aureocort®
Ointment (triamcinolone 0.1% and chlortetracycline 3%)
13.4.3 Compound preparations
13.4.3.1 Mild
Eurax-Hydrocortisone®
Cream (hydrocortisone 0.25% and crotamiton 10%)
13.4.3.2 Moderate
Alphaderm®
Cream (hydrocortisone 1% and urea 10%)
Calmurid HC®
Cream (hydrocortisone 1%, urea 10%, lactic acid 5%)
13.4.4 Steroid scalp applications
13.4.4.1 Potent
Betamethasone 0.1%
(Betacap®) scalp application, (Betnovate®) scalp application, (Bettamousse®) foam scalp application
Diprosalic®
Scalp application (betamethasone 0.05% and salicyclic acid 2%)
Synalar®
Gel (fluocinolone acetonide 0.025%)
13.4.4.2 Very Potent
Clobetasol propionate 0.05%
- Dermovate® scalp application
- Clarelux® foam
- Etrivex® shampoo
13.5 Preparations for Eczema and Psoriasis
13.5.1 Preparations for eczema
Please refer to section 13.2 (emollients) and 13.4 (topical corticosteroids).
Specific Indication
Ichthopaste®
(zinc paste and ichthammol) bandage – only to be applied by a Nurse skilled in paste bandage appplication
Steripaste®
Zinc Bandages. Only to be applied by a Nurse skilled in paste bandage appplication
Zipzoc®
(zinc paste) bandage
13.5.1.1 Oral retinoid for eczema
Alitretinoin
Severe chronic hand eczema: NICE TA177
13.5.2 Preparations for psoriasis
Topical preparations
Please refer to the BNF for information regarding vitamin D and analogues.
13.5.2.1 Vitamin D and analogues
Dovonex®
Scalp solution (calcipotriol)
Dovobet®
Gel (calcipotriol with betamethasone 0.05%) – body and scalp
Enstilar®
Cutaneous foam (calcipotriol with betamethasone 0.05%)
Silkis®
Ointment (calcitriol 3micrograms/g)
13.5.2.2 Topical retinoid
Tazarotene
0.05%, 0.1% gel
13.5.2.3 Compound product
Chelsea Day mix (Hospital Formula) is only available as a ‘special’ preparation (i.e. not a proprietary product).
These preparations are not cost-effective in primary care and there may be a significant delay in obtaining such preparations.
Chelsea Day mix
(Hospital Formula) possible price on FP10 prescription: up to £250 for 100g
13.5.2.4 Coal tar
Chelsea Night mix and Coal Tar 5% in Eumovate® ointments are only available as ‘special’ preparations (i.e. not proprietary products).
These preparations are not cost-effective in primary care and there may be a significant delay in obtaining such preparations.
Cocois®
Scalp ointment
Exorex®
Lotion
Alphosyl HC®
Cream (with hydrocortisone 0.5%)
Polytar Emollient®
Bath additive (contains peanut oil)
Coal Tar 5% in Eumovate®
Ointment possible price on FP10 prescription: up to £588 for 500g
Chelsea Night mix
Possible price on FP10 prescription: up to £250 for 100g
13.5.2.5 Dithranol
Dithrocream®
0.1%, 0.25%, 0.5%, 1% and 2% - specialist use only
Micanol®
- 1%, 3% cream.
- Specialist use only
Dithranol in Lassar’s Paste
- 0.1%, 0.25%, 0.5%, 1%, 2%, 4%
- Specialist use only
Dithranol in Lassar's Paste
GHNHSFT Local Guideline
Dithranol in Lassar's Paste
Sample drug chart
13.5.2.6 Salicylic Acid
The 'amber' topical salicylic acid preparations below are only available as ‘special’ preparations (i.e. not proprietary products).
These preparations are not cost-effective in primary care and there may be a significant delay in obtaining such preparations.
Salicylic acid 2% ointment
Possible price on FP10 prescription: £1 for 100g
Salicylic acid 5% in white soft paraffin
- Second-line to Flexitol® (see section 13.2.4.5)
- Possible price on FP10 prescription: up to £100 for 100g
Salicylic acid 10% in white soft paraffin
- Second-line to Flexitol® (see section 13.2.4.5)
- Possible price on FP10 prescription: up to £100 for 100g
13.5.2.7 Oral retinoids for psoriasis
Acitretin
Specialist use only
13.5.3 Drugs affecting the immune response
13.5.3.1 Topical
Protopic®
Ointment (tacrolimus 0.03% and 0.1%) – NICE TA82
Elidel®
Cream (pimecrolimus 1%) – NICE TA82
13.5.3.2 Systemic
Ciclosporin
Methotrexate
Abrocitinib
Atopic dermatitis: NICE TA814
Adalimumab
Psoriasis: NICE TA146, NICE TA455
Apremilast
Psoriasis: NICE TA419
Baricitinib
Atopic dermatitis: NICE TA681
Bimekizumab
Psoriasis: NICE TA723
Brodalumab
Psoriasis: NICE TA511
Certolizumab
Psoriasis: NICE TA574
Deucravacitinib
Psoriasis: NICE TA907
Dimethyl fumarate
Psoriasis:
- NICE TA475
- Local Criteria Based Access scheme
Dupilumab
Atopic dermatitis: NICE TA534
Etanercept
Psoriasis: NICE TA103, NICE TA455
Guselkumab
Psoriasis: NICE TA521
Infliximab
Psoriasis: NICE TA134
Ixekizumab
Psoriasis: NICE TA442
Lebrikizumab
Atopic dermatitis: NICE TA986
Risankizumab
Psoriasis: NICE TA596
Secukinumab
Psoriasis: NICE TA350, NICE TA734
Tildrakizumab
Psoriais: NICE TA575
Tralokinumab
Atopic dermatitis: NICE TA814
Upadacitinib
Atopic dermatitis: NICE TA814
Ustekinumab
Psoriasis: NICE TA180, NICE TA455
13.6 Acne and rosacea
13.6.1 Comedonal Acne
Recommended
Brevoxyl®
Cream (benzoyl peroxide 4%)
Differin®
Cream / gel (adapalene 0.1%)
Skinoren®
Cream (azelaic acid 20%)
13.6.2 Mild to Moderate Papulopustular Acne
Recommended
Aklief®
Cream (trifarotene 50mcg/g)
First-line for truncal acne
Duac®
Gel (benzoyl peroxide 5% + clindamycin 1%)
Duac®
Gel (benzoyl peroxide 3% + clindamycin 1%)
Epiduo®
Gel (adapalene 0.1% + benzoyl peroxide 2.5%)
Treclin®
Gel (tretinoin 0.025% + clindamycin 1%)
Oral antibiotics
(see 13.6.2) PLUS above topical treatment – where topical treatment alone is ineffective
13.6.3 Severe acne: Specialist initiation only
Isotretinoin
Specialist use only
13.6.4 Topical preparations for rosacea
Recommended
Finacea®
Gel (azelaic acid 15%)
Rozex®
Gel/cream (metronidazole 0.75%)
Specific Indication
Soolantra®
Cream (ivermectin 10mg/g) – where the recommended choices are ineffective or not tolerated
13.6.5 Oral antibacterials for acne and rosacea
Recommended
Doxycycline
100mg
Lymecycline
Specific Indication
Doxycycline MR
(Efracea®) 40mg od – Strictly reserved for patients wfho have demonstrated a definite intolerance to the recommended options
13.7 Preparations for warts and calluses
Salactol®
Paint (salicylic acid 16.7% and lactic acid 16.7%)
Posalfilin®
Ointmefnt (salicylic acid 25% and podophyllum 20%)
Cantharone Plus®
(cantharidin, podophyllum resin, salicylic acid) – unlicensed
13.7.1 Anogenital warts
Ideally all patients should first receive a full genito-urinary screen at GUM but there may be circumstances when Dermatologists may need to prescribe.
Warticon®
Cream (podophyllotoxin)
Aldara®
Cream (imiquimod 5%)
13.8 Sunscreens and camouflagers
13.8.1 Sunscreen preparations
Recommended
Anthelios® Sunscreen Lotion SPF 50+
Alternative
Uvistat® Suncream SPF 50
Uvistat® Lipscreen SPF 50
Uvistat® Suncream SPF 30
13.8.2 Photodamage Actinic Keratosis
Recommended
Efudix®
Cream (fluorouracil 5%)
Klisyri®
Ointment (tirbanibulin 10mg/g)
Specific Indication
Actikerall®
Solution (Fluorouracil 0.5%, salycylic acid 10%) – Hypertrophic actinic keratosis. Lesion treatment where cryotherapy unavailable
Aldara® cream
(imiquimod 5%) – patients who have failed to respond to other options
Metvix® cream
(Methyl-5-Aminolevulinate). Treatment of actinic keratoses, superficial or nodular basal cell carcinoma and Bowen's Disease
13.8.3 Miscellaneous
Pigmanorm®
Cream (hydroquinone 5%, tretinoin 0.1%, hydrocortisone 1%) – melanin-induced hyperpigmentation of the skin (unlicensed)
13.9 Shampoos and other preparations for scalp and hair conditions
Please refer to the BNF for information regarding constituents.
Alphosyl 2 in 1®
Shampoo
Capasal®
Shampoo
Dermax®
Shampoo
Ketoconazole 2%
Shampoo
Polytar®
Liquid
13.10 Anti-infective skin preparations
13.10.1 Antibacterial preparations
13.10.1.1 Antibacterial preparations only used topically
Bactroban®
Mupirocin 2% cream
Polyfax®
Polymixin B sulphate and bacitracin zinc ointment
Flamazine®
Silver sulfadiazine 1% cream
13.10.1.2 Antibacterial preparations also used systemically
Fucidin®
Ointment/cream (fusidic acid 2%)
Rozex®
Gel/cream (metronidazole 0.75%) – For malodorous tumours and skin ulcers
13.10.1.3 Rosacea
Rozex®
Gel/cream (metronidazole 0.75%)
13.10.2 Antifungal preparations
Recommended
Clotrimazole 1%
Cream/solution
Alternative
Miconazole 2%
Cream
Terbinafine 1%
Cream
Nystatin
Cream/ointment
Nizoral®
Cream (Ketoconazole 2%)
Specific Indication
Amorolfine 5%
Nail laquer (prescribe generically) – nail infections, where oral therapy is contra-indicated.
13.10.3 Antiviral preparations
Aciclovir 5%
Cream - should only be started at first sign of attack.
13.10.4 Parasiticidal preparations
Hedrin®
Lotion (Dimeticone 4%)
Derbac M®
Aqueous liquid (Malathion 0.5%)
Lyclear®
Dermal cream (Permethrin 5%)
13.10.5 Preparations for minor cuts and abrasions
Skin tissue adhesive
LiquiBand®
Histoacryl®
13.11 Skin cleansers and antiseptics
GHNHSFT Local Guideline: Infection Control Policy
13.11.1 Oxidisers and dyes
Permitabs®
(Potassium permanganate) 400mg
For external use only, toxic if swallowed. Only prescribe where use is absolutely necessary, and safe handling and storage have been clearly discussed.
Potassium permanganate application policy
GHNHSFT Local Guideline: Potassium permanganate application policy (intranet)
13.12 Antiperspirants
Driclor®
(Aluminium chloride hexahydrate 20%)
13.13 Wound management products and elastic hosiery
Gloucestershire Wound Management Formulary
13.13.1 Topical treatments for scar reduction
Dermatix®
Gel
13.14 Miscellaneous
Adalimumab
Moderate to severe hidradenitis suppurativa as per NICE TA392
Secukinumab
Moderate to severe hidradenitis suppurativa as per NICE TA935
Birch bark extract (Filsuvez® gel)
Epidermolysis bullosa, as per NICE HST28
Ritlecitinib
Severe alopecia areata, as per NICE TA958
On this page
-
Management of skin conditions
-
Emollient and barrier preparations
-
Antipruritics
-
Topical corticosteroids
-
Preparations for Eczema and Psoriasis
-
Acne and rosacea
-
Preparations for warts and calluses
-
Sunscreens and camouflagers
-
Shampoos and other preparations for scalp and hair conditions
-
Anti-infective skin preparations
-
Skin cleansers and antiseptics
-
Antiperspirants
-
Wound management products and elastic hosiery
-
Miscellaneous